Ethical Issues in Gene Therapy 
Protection of Human Subject*, 45 Code of Federal Regulations 46, 101—409. 
Office of Protection from Research Risks, National Institutes of Health. 
(Sources: Federal Register 46, 8386, January 26, 1981; Federal Register 48, 
9269, March 4, 1983.) 
Rawls, R. L.: 1984, ‘Progress in gene therapy brings human trials near’. Chemical 
and Engineering News, August 14, pp. 39—44. 
Report of a Working Party: 1984, Protection of Impaired Human Subjects of 
Research, Clinical Center, National Institutes of Health. 
Rjfkin, J.: 1983, Algeny, Viking Press, New York. 
Robertson, J. A.: 1983, The Rights of the Critically Til, Ballinger Publ. Co., 
Cambridge, Massachusetts, pp. 80—96. 
Thompson, L.: 1984, 'Researchers ready to try gene therapy’, Washington Post, 
December 19, p. D7. 
Tran6y, K. E.: 1983, is there a universal research ethics?', in K. Berg and K. E. 
Tran^y (eds.), Research Ethics, Alan R. Liss, pp. 3 — 12. 
U.S. Congress: 1982, Human Genetic Engineering, Hearings Before the Subcom- 
mittee on Investigations and Oversight of the Committee on Science and 
Technology, U.S. Government Printing Office, Washington, D.C., pp. 301 — 
346. 
U.S. Congress: Office of Technology Assessment, 1984: Human Gene Therapy — 
A Background Paper, Washington, D.C. (OTA-BP-BA-32). 
Recombinant DNA Research, Volume 12 
[351] 
